Medical News

Wall Street Journal Examines Study of Medical Outliers to Fight Disease

October 20, 2009

The Wall Street Journal examines how scientists are studying patients known as "elite controllers," who "are part of a larger group of 'outliers,' people who respond atypically to a disease, often by managing to stop it from progressing or by succumbing especially quickly. If researchers can figure out how elite controllers avoid developing AIDS, they might be able to replicate the defenses in other people through a vaccine or new drug." The article profiles an HIV-positive man who has maintained "an extremely low viral count despite having never received antiretroviral therapy" and includes information on several controllers projects on HIV and hepatitis C have that have yielded promising results (Marcus, 10/20).

Back to other news for October 2009

This information was reprinted from with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.